Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson's Disease

被引:7
作者
Seemiller, Joseph [1 ,5 ]
Morrow, Christopher [2 ]
Hinkle, Jared T. [2 ]
Perepezko, Kate [3 ]
Kamath, Vidyulata [2 ]
Pontone, Gregory M. [2 ,4 ]
Mills, Kelly A. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA
[3] Univ Pittsburgh, Natl Rehabil Res & Training Ctr Family Support, Pittsburgh, PA USA
[4] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL USA
[5] Johns Hopkins Sch Med, Dept Neurol, 600 N Wolfe St,Meyer 6-181, Baltimore, MD 21287 USA
关键词
Parkinson's disease; dopamine overdose; symbol digit modalities test; Stroop test; DIGIT MODALITIES TEST; WORKING-MEMORY; MULTIPLE-SCLEROSIS; DEFICITS; IMPAIRMENT; STROOP; INTERFERENCE; PERFORMANCE; MODULATION; LEVODOPA;
D O I
10.1002/mdc3.14017
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: PD causes striatal dopaminergic denervation in a posterior/dorsal to anterior/ventral gradient, leaving motor and associative cortico-striato-pallido-thalamic loops differentially susceptible to hyperdopaminergic effects with treatment. As the choice and titration of symptomatic PD medications are guided primarily by motor symptoms, it is important to understand their cognitive implications. Objective: To investigate the effects of acute dopaminergic medication administration on executive function in Parkinson's disease (PD). Methods: Participants with idiopathic PD were administered the oral Symbol Digit Modalities Test (SDMT; n = 181) and the Stroop test (n = 172) in the off-medication and "best on" medication states. ANCOVA was used to test for differences between off-medication and on-medication scores corrected for age and years of education. Results: After administration of symptomatic medications, scores worsened on the SDMT (F = 11.70, P < 0.001, d = -0.13), improved on the Stroop color (F = 26.89, P < 0.001, d = 0.184), word (F = 6.25, P = 0.013, d = 0.09), and color-word (F = 13.22, P < 0.001, d = 0.16) test components, and the Stroop difference and ratio-based interference scores did not significantly change. Longer disease duration correlated with lower scores on the SDMT, Stroop color, word, and color-word scores; however, longer disease duration and higher levodopa-equivalents correlated with higher Stroop difference-based interference scores. Conclusions: Symptomatic medication differentially affects performance on two cognitive tests in PD. After acute treatment, core Stroop measures improved, Stroop interference was unchanged, and SDMT performance worsened, likely reflecting complex changes in processing speed and executive function related to acute treatment. When considering motor symptom therapies in PD, an individual's cognitive demands and expectations, especially regarding executive function, should be considered.
引用
收藏
页码:534 / 542
页数:9
相关论文
共 75 条
[1]   Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Kragh-Sorensen, P .
ARCHIVES OF NEUROLOGY, 2003, 60 (03) :387-392
[2]   PARALLEL ORGANIZATION OF FUNCTIONALLY SEGREGATED CIRCUITS LINKING BASAL GANGLIA AND CORTEX [J].
ALEXANDER, GE ;
DELONG, MR ;
STRICK, PL .
ANNUAL REVIEW OF NEUROSCIENCE, 1986, 9 :357-381
[3]   Can the Stroop effect serve as the gold standard of conflict monitoring and control? A conceptual critique [J].
Algom, Daniel ;
Fitousi, Daniel ;
Chajut, Eran .
MEMORY & COGNITION, 2022, 50 (05) :883-897
[4]   Network modulation in the treatment of Parkinson's disease [J].
Asanuma, Kotaro ;
Tang, Chengke ;
Ma, Yilong ;
Dhawan, Vijay ;
Mattis, Paul ;
Edwards, Christine ;
Kaplitt, Michael G. ;
Feigin, Andrew ;
Eidelberg, David .
BRAIN, 2006, 129 :2667-2678
[5]   Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis [J].
Baiano, Chiara ;
Barone, Paolo ;
Trojano, Luigi ;
Santangelo, Gabriella .
MOVEMENT DISORDERS, 2020, 35 (01) :45-54
[6]   The Stroop Effect Occurs at Multiple Points Along a Cascade of Control: Evidence From Cognitive Neuroscience Approaches [J].
Banich, Marie T. .
FRONTIERS IN PSYCHOLOGY, 2019, 10
[7]   Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues [J].
Benedict, Ralph H. B. ;
Amato, Maria Pia ;
DeLuca, John ;
Geurt, Jeroen J. G. .
LANCET NEUROLOGY, 2020, 19 (10) :860-871
[8]   Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis [J].
Benedict, Ralph H. B. ;
DeLuca, John ;
Phillips, Glenn ;
LaRocca, Nicholas ;
Hudson, Lynn D. ;
Rudick, Richard .
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (05) :721-733
[9]   Minimal neuropsychological assessment of MS patients: A consensus approach [J].
Benedict, RHB ;
Fischer, JS ;
Archibald, CJ ;
Arnett, PA ;
Beatty, WW ;
Bobholz, J ;
Chelune, GJ ;
Fisk, JD ;
Langdon, DW ;
Caruso, L ;
Foley, F ;
LaRocca, NG ;
Vowels, L ;
Weinstein, A ;
DeLuca, J ;
Rao, SM ;
Munschauer, F .
CLINICAL NEUROPSYCHOLOGIST, 2002, 16 (03) :381-397
[10]   Conflict monitoring and cognitive control [J].
Botvinick, MM ;
Braver, TS ;
Barch, DM ;
Carter, CS ;
Cohen, JD .
PSYCHOLOGICAL REVIEW, 2001, 108 (03) :624-652